Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
Holding LOVFF?
Track your performance easily
LOVFF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.39 - $0.78
Previous CloseN/A
Volume3.00K
Average Volume (3M)14.06K
Market Cap
$52.81M
Enterprise Value$102.92M
Total Cash (Recent Filing)$12.90M
Total Debt (Recent Filing)$12.95M
Price to Earnings (P/E)11.6
Beta0.26
Next Earnings
Jan 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding90,018,950
10 Day Avg. Volume5,271
30 Day Avg. Volume14,058
Standard Deviation0.13
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.93
Price to Cash Flow (P/CF)5.20
P/FCF Ratio11.40
Enterprise Value/Market Cap1.95
Enterprise Value/Revenue1.25
Enterprise Value/Gross Profit3.69
Enterprise Value/Ebitda6.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cannara Biotech News
PremiumCompany Announcements
Cannara Biotech Achieves Record Growth in Q1 2025, Plans Expansion
PremiumCompany Announcements
Cannara Biotech Hosts Investor Webcast in December
PremiumCompany Announcements
Cannara Biotech Reports Record Growth in 2024
PremiumCompany Announcements
Cannara Biotech Hits Record Market Share in July
Options Prices
Currently, No data available
---
Ownership Overview
LOVFF FAQ
What was Cannara Biotech’s price range in the past 12 months?
Cannara Biotech lowest stock price was $0.39 and its highest was $0.78 in the past 12 months.
What is Cannara Biotech’s market cap?
Cannara Biotech’s market cap is $52.81M.
When is Cannara Biotech’s upcoming earnings report date?
Cannara Biotech’s upcoming earnings report date is Jan 27, 2025 which is 4 days ago.
How were Cannara Biotech’s earnings last quarter?
Cannara Biotech released its earnings results on Jan 27, 2025. The company reported $0.018 earnings per share for the quarter, beating the consensus estimate of N/A by $0.018.
Is Cannara Biotech overvalued?
According to Wall Street analysts Cannara Biotech’s price is currently Overvalued.
Does Cannara Biotech pay dividends?
Cannara Biotech does not currently pay dividends.
What is Cannara Biotech’s EPS estimate?
Cannara Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cannara Biotech have?
Cannara Biotech has 90,018,950 shares outstanding.
What happened to Cannara Biotech’s price movement after its last earnings report?
Cannara Biotech reported an EPS of $0.018 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of Cannara Biotech?
Currently, no hedge funds are holding shares in LOVFF
---
Company Description
Cannara Biotech
Cannara Biotech Inc is engaged in production of indoor cannabis and derivative products for the Canadian and international markets. The company is building indoor cannabis cultivation facility in Quebec, Canada.
---
Technical Analysis
---